Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Tailor treatment in the older patient with type 2 diabetes.

Abdelhafiz AH, Sinclair AJ.

Practitioner. 2013 Jan;257(1757):21-5, 2-3.

PMID:
23469724
2.

The elderly Type 2 diabetic patient: special considerations.

Morley JE.

Diabet Med. 1998;15 Suppl 4:S41-6. Review.

PMID:
9868991
4.

Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.

Greco D, Angileri G.

Diabetes Nutr Metab. 2004 Feb;17(1):23-6.

PMID:
15163121
5.

Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.

Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald I, Amiel S.

Diabetes Care. 1998 Feb;21(2):283-90.

PMID:
9539997
6.

Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.

Tandon N, Ali MK, Narayan KM.

Am J Cardiovasc Drugs. 2012 Feb 1;12(1):7-22. doi: 10.2165/11594650-000000000-00000. Review.

PMID:
22217193
7.

Glucose control in the older patient: from intensive, to effective and safe.

Dominguez LJ, Paolisso G, Barbagallo M.

Aging Clin Exp Res. 2010 Aug;22(4):274-80. doi: 10.3275/6629. Epub 2009 Nov 17. Review.

PMID:
19934622
8.

Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.

Choudhary P, Lonnen K, Emery CJ, MacDonald IA, MacLeod KM, Amiel SA, Heller SR.

Diabet Med. 2009 Jul;26(7):665-72. doi: 10.1111/j.1464-5491.2009.02759.x.

PMID:
19573114
9.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
10.

Glycaemic instability is an underestimated problem in Type II diabetes.

Praet SF, Manders RJ, Meex RC, Lieverse AG, Stehouwer CD, Kuipers H, Keizer HA, van Loon LJ.

Clin Sci (Lond). 2006 Aug;111(2):119-26.

PMID:
16613586
11.

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.

Blicklé JF, Hancu N, Piletic M, Profozic V, Shestakova M, Dain MP, Jacqueminet S, Grimaldi A.

Diabetes Obes Metab. 2009 Apr;11(4):379-86. doi: 10.1111/j.1463-1326.2008.00980.x. Epub 2008 Dec 14.

PMID:
19087105
12.

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

Clin Ther. 2001 Oct;23(10):1732-44.

PMID:
11726007
14.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
15.

The symptoms of hyperglycaemia in people with insulin-treated diabetes: classification using principal components analysis.

Warren RE, Deary IJ, Frier BM.

Diabetes Metab Res Rev. 2003 Sep-Oct;19(5):408-14.

PMID:
12951649
16.

[Hypoglycemia--a dreaded complication of diabetes].

Bjørgaas M.

Tidsskr Nor Laegeforen. 2000 Aug 30;120(20):2441-4. Review. Norwegian.

PMID:
11475234
17.

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.

Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM; PRESENT Study Group.

Diabetes Obes Metab. 2008 Mar;10(3):212-22. doi: 10.1111/j.1463-1326.2007.00826.x.

PMID:
18269636
18.

Relationship between interstitial and blood glucose during hypoglycemia in subjects with type 2 diabetes.

Choudhary P, Lonnen K, Emery CJ, Freeman JV, McLeod KM, Heller SR.

Diabetes Technol Ther. 2011 Nov;13(11):1121-7. doi: 10.1089/dia.2011.0059. Epub 2011 Jul 26.

PMID:
21790477
19.
20.

Supplemental Content

Support Center